Scientists are 3-D printing miniature human organs to test coronavirus drugs


Whether the goal is to find a treatment for COVID-19 or another disease, scientists often have to conduct preliminary tests on animals to determine whether the drug is safe or effective in people. It's not always a one-for-one comparison, but The New York Times reports there may be a new way around that step going forward: 3-D printing.
For example, Anthony Atala, the director of the Wake Forest Institute for Regenerative Medicine, and his team are using 3-D printers to create tiny replicas of human organs, including miniature lungs and colons, which are particularly affected by the coronavirus. They send them overnight for testing at a biosafety lab at George Mason University.
The idea predated the coronavirus — Atala said he never thought "we'd be considering this for a pandemic" — but it could come in handy and help expedite the experimental drug process, especially since Atala said his Winston-Salem, North Carolina-based lab can churn out thousands of printed organs per hour. "The 3-D models can circumvent animal testing and make the pathway stronger from the lab to the clinic," said Akhilesh Gaharwar, who directs a lab in the biomedical engineering at Texas A&M University. Read more at The New York Times.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.